Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mesothelioma Victims Center Urges Diagnosed Victims Nationwide To Check Out Philadelphia's Fox Chase Cancer Center's Website Because of It's Constant Research Updates
  • USA - English


News provided by

Americas Watchdog 5

Oct 10, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


(PRWEB) October 10, 2014 -- The Mesothelioma Victims Center is urging diagnosed victims of mesothelioma in Pennsylvania, West Virginia, or nationwide to strongly consider reaching out to the Fox Chase Cancer Center in Philadelphia for information about possible treatment options for mesothelioma. By coincidence, the CDC ranks Pennsylvania and West Virginia in the top six states for the incidence of mesothelioma.

Fox Chase enjoys an enviable reputation for research — two of its scientists won Nobel Prizes, one for history’s first cancer vaccine

Post this

The Victims Center believes the Fox Chase Cancer Center's website focused on mesothelioma might be one of the best in the nation, because it is constantly being updated with new information about mesothelioma treatment options, and research.

More about the Fox Chase Cancer Center in Philadelphia: "At Fox Chase Cancer Center, new technologies and cancer treatments often are available before becoming standard practice in the broader cancer-care community. For example, it offers CancerCode, a DNA sequencing test allowing tumor-specific genetic alterations to be precisely matched with a choice of chemotherapy drugs likely to work best for the individual patient.

"Fox Chase enjoys an enviable reputation for research — two of its scientists won Nobel Prizes, one for history’s first cancer vaccine. It operates state-of-the-art lab facilities in support of biotechnology, clinical, cell biology, computing/information, and genetic research."

For attribution please see: http://www.mesotheliomaclinic.org/fox-chase-cancer-center/

The Center is urging diagnosed victims of mesothelioma or their family members to call 866-714-6466 before retaining the services of an attorney to advance a mesothelioma compensation claim. They are convinced most diagnosed victims of mesothelioma get financially short changed as a result of hiring an inexperienced law firm, or retaining the services of a mesothelioma middleman marketing law firm that advertises on cable TV.

Before any diagnosed victim of mesothelioma or their family hires an attorney to advance a mesothelioma compensation claim, they are urged to contact the Mesothelioma Victims Center at 866-714-6466, in order to ensure they are dealing with the nation's best mesothelioma compensation lawyers. http://MesotheliomaVictimsCenter.Com

Information About Mesothelioma For Diagnosed Victims And Their Families From The Mesothelioma Victims Center:

High risk work groups for exposure to asbestos include US Navy Veterans, shipyard workers, oil refinery workers, power plant workers, manufacturing workers, coal miners, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s. http://MesotheliomaVictimsCenter.Com

According to the US Center for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2500, and 3000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.

According to the CDC, the states with the highest incidence of mesothelioma include Pennsylvania, Maine, New Jersey, West Virginia, Florida, Wyoming, and Washington. However, based on the calls the Mesothelioma Victims Center receives diagnosed victims could be in any state including California, New York, Texas, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Louisiana, Missouri, Ohio, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Montana, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, and Alaska.

The Mesothelioma Victims Center says, “Before you hire a mesothelioma attorney please call us at 866-714-6466, and compare the qualifications of who we consider to be the nation's most skilled mesothelioma attorneys to any other lawyer, or law firm. When it comes to obtaining the best mesothelioma compensation settlement, the quality of the attorney matters, as we would like to explain anytime." http://MesotheliomaVictimsCenter.Com

For more information about a rare form of cancer caused by exposure to asbestos called mesothelioma, please visit the US Centers For Disease Control's web site: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a3.htm

M Thomas Martin, Americas Watchdog 5, http://MesotheliomaCompensationCenter.com, +1 (866) 714-6466, [email protected]

Modal title

Asbestos Warning Sign
Asbestos Warning Sign
Asbestos Warning Sign

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.